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Abstract 1 
Background: Leg pain is associated with back pain in 25-65% of all cases and 2 
classified as somatic referred pain or radicular pain. However, distinction between the 3 
two may be difficult as different pathomechanisms may cause similar patterns of pain. 4 
Therefore a pathomechanism based classification system was proposed, with four 5 
distinct hierarchical and mutually exclusive categories: Neuropathic Sensitization 6 
(NS) comprising major features of neuropathic pain with sensory sensitization; 7 
Denervation (D) arising from significant axonal compromise; Peripheral Nerve 8 
Sensitization (PNS) with marked nerve trunk mechanosensitivity; and 9 
Musculoskeletal (M) with pain referred from musculoskeletal structures.  10 
Objective: To investigate construct validity of the classification system 11 
Methods: Construct validity was investigated by determining the relationship of 12 
nerve functioning with subgroups of patients and asymptomatic controls. Thus 13 
somatosensory profiles of subgroups of patients with low back related leg pain 14 
(LBRLP) and healthy controls were determined by a comprehensive quantitative 15 
sensory test (QST) protocol. It was hypothesized that subgroups of patients and 16 
healthy controls would show differences in QST profiles relating to underlying 17 
pathomechanisms. 18 
Results: 77 subjects with LBRLP were recruited and classified in one of the four 19 
groups. Additionally, 18 age and gender matched asymptomatic controls were 20 
measured. QST revealed signs of pain hypersensitivity in group NS and sensory 21 
deficits in group D whereas Groups PNS and M showed no significant differences 22 
when compared to the asymptomatic group.  23 
 
 3 
Conclusions: These findings support construct validity for two of the categories of 1 
the new classification system, however further research is warranted to achieve 2 
construct validation of the classification system as a whole. 3 
 4 
Keywords: Low back pain, Leg pain, Classification system, Validity, Quantitative 5 
Sensory Testing, QST 6 
  7 
 
 4 
1. Introduction 1 
Low back related leg pain (LBRLP) is common with up to 65% of patients with low 2 
back pain reporting accompanying leg pain [1, 2]. These cases account for a 3 
disproportionately large amount of the costs of medical care and disability 4 
compensation caused by low back pain (LBP) [3] as leg pain is associated with more 5 
severe pain and disability outcomes [4]. Traditionally, LBRLP is classified as somatic 6 
referred pain (“pseudoradicular pain”) or projected radicular pain [5]. However, 7 
despite advanced diagnostic technology, the distinction between these two entities 8 
remains difficult as different structures in the lower back can evoke similar patterns of 9 
pain. Pain radiating as far as the toes can stem from intervertebral disks, 10 
zygapophyseal joints, muscles, and fascia in addition to the lumbar nerve roots [6-8]. 11 
 12 
Randomized controlled trials investigating the effectiveness of conservative treatment 13 
of patients with radiating leg pain show inconsistent findings [9, 10]. One explanation 14 
for this could be the failure to correctly classify subjects into homogenous treatment-15 
specific subgroups, with consequent lack of effect due to inappropriate treatment. 16 
There are recommendations from the pain literature that for the more complex pain 17 
conditions related to nerve injury a classification system based on pathomechanisms 18 
offers greater diagnostic and treatment value and may also provide information about 19 
the prognosis and natural course of the disorder [11].  20 
 21 
In order to refine the differentiation of radicular and pseudoradicular pain and hence 22 
gain treatment efficacy, we introduced a new mechanism based classification system 23 
[12] based on the original classification proposed by Elvey and Hall [13]. The aim of 24 
this system is to improve treatment outcome, particularly with respect to identifying 25 
 
 5 
patients most likely to respond to neural mobilization. Depending on the assumed 1 
predominance of pathomechanisms, LBRLP is classified into four distinct subgroups. 2 
Prioritized, these categories are (Figure 1):  3 
1. Neuropathic Sensitization (NS) comprising major features of neuropathic pain 4 
mechanisms with dominant sensory sensitization 5 
2. Denervation (D) caused by significant peripheral axonal compromise with 6 
evidence of afferent and / or efferent loss of conduction in the absence of 7 
dominant sensory sensitization 8 
3. Peripheral Nerve Sensitization (PNS) presumably arising from nerve trunk 9 
inflammation. Patients in this group are characterized by positive nerve 10 
provocation tests (e.g. straight leg raise test) without clinical evidence of 11 
significant denervation and absent dominant features of neuropathic pain 12 
mechanisms. 13 
4. Musculoskeletal (M) with pain referred from non-neural structures such as the 14 
disc or facet joints. Patients in this group are characterized by absent features 15 
of neuropathic pain mechanisms, absent signs of denervation and negative 16 
nerve provocation tests. 17 
 18 
This new classification system has demonstrated good interrater reliability with  = 19 
0.72 [14] and has shown prognostic ability [15]. The objective of the present study 20 
was to investigate construct validity of the classification system by determining the 21 
relationship of diagnostic groups with the results from Quantitative Sensory Testing 22 
(QST) [16].  23 
 24 
 
 6 
2. Methods 1 
Study design and hypotheses 2 
This observational, cross-sectional study was designed to investigate construct 3 
validity of a new classification system for subjects with LBRLP. Construct validity is 4 
based on testing hypotheses about relationships of the instrument under study (i.e. the 5 
classification system) with other instruments measuring similar constructs [16]. The 6 
construct measured both by the instrument under study (i.e. the classification system) 7 
and the reference instrument (QST) is pain mechanisms. We tested the hypothesis that 8 
QST parameters will differ between subgroups of subjects with LBRLP and a group 9 
of asymptomatic subjects. 10 
Ethical approval 11 
This study was approved by the Human Research Ethics Committee of the Curtin 12 
University of Technology. All patients provided written informed consent prior to 13 
participating in the study. 14 
Subjects and recruitment 15 
Subjects were recruited at a multidisciplinary pain clinic in Hamburg, Germany. 162 16 
consecutive patients with LBRLP referred for physiotherapy at the clinic were 17 
screened for eligibility. To be considered for inclusion subjects were required to be 18 
between 18 and 75 years of age, with unilateral LBRLP of more than 6 weeks 19 
duration. Exclusion criteria were history of lower quadrant surgery or trauma within 20 
the past 6 months, nerve root block within the past four weeks, other neuropathic 21 
pathology such as diabetes or polyneuropathies, vascular disease in the lower 22 
extremities, inflammatory arthropathies, contraindications to manual therapy 23 
techniques and inability to understand written / spoken German. Of the 162 subjects 24 
 
 7 
screened, 77 were eligible and willing to participate (Figure 2). Another 18 age and 1 
gender matched healthy volunteers were recruited as control subjects to provide 2 
normative data for z-score standardization of QST parameters into standard deviation 3 
units for comparison.  4 
Quantitative sensory testing (QST) 5 
A comprehensive battery of QST devices that was developed and validated by the 6 
German Research Network on Neuropathic Pain [17] was used as the reference 7 
instrument.  8 
 9 
This QST battery tests all relevant submodalities of the somatosensory system.  10 
 Seven tests are used to measure 13 parameters consisting of thermal pain thresholds 11 
for cold and hot stimuli; thermal detection thresholds for the perception of cold, warm 12 
and thermal sensory limen1; paradoxical heat sensations; mechanical pain thresholds 13 
for pinprick and blunt pressure; mechanical detection thresholds for touch and 14 
vibration; a stimulus-response-function for pinprick sensitivity; dynamic mechanical 15 
allodynia for stroking light touch; as well as pain summation to repetitive pinprick 16 
stimuli. Thus QST evaluates the function of sensory nerve fibres and their respective 17 
pathways [18] by analysing multiple parameters of sensory testing. Thus obtained 18 
sensory profiles of patients may exhibit whether dominant features of sensory deficit 19 
(loss of function) or sensory hyperexcitability (gain of function) exist, indicative for 20 
specific pain mechanisms [19, 20]. 21 
 22 
 The test protocol has been shown to have good test-retest and inter-tester reliability 23 
                                               
1 Thermal sensory limen is the difference in sensory threshold between alternating cold and warm 
stimuli 
 
 8 
[21] as well as acceptable concurrent validity [22-24]. 1 
 2 
We tested three body regions; the lower back, the dorsum of the foot and the dorsum 3 
of the hand. In subjects with LBRLP test sites were within the painful region of the 4 
back and on the dorsum of the affected foot. A site remote to the painful regions 5 
(dorsum of the ipsilateral hand) was also tested, as changes in the somatosensory 6 
system associated with chronic pain have also been reported in body areas remote to 7 
the source of pain. It has been shown that these changes manifest in negative signs 8 
such as hypoesthesia [25] as well as in positive signs such as pain sensitivity to blunt 9 
pressure [26]. The ipsilateral hand was always tested first, followed alternately by foot 10 
or back in patient groups. In the control group, testing of the different areas was 11 
conducted alternately.  12 
Classification 13 
All symptomatic subjects were classified into one of four groups following a pre-14 
established examination protocol [12] (Figure 1). The assessment protocol includes 15 
subjective questions relating to area of pain, duration of symptoms, and aggravating 16 
and easing factors. The subjective components of the LANSS questionnaire [27] were 17 
incorporated into the subjective assessment to screen for predominantly positive 18 
symptoms indicative of sensitization of the somatosensory system. The physical 19 
examination included a neurological examination to screen for motor and sensory 20 
deficits, neural tissue provocation tests (straight leg raise test; prone knee bend test, 21 
active flexion test in standing, nerve palpation) [13] and the objective components for 22 
the total LANSS score (altered pin prick sensation and light touch allodynia).  23 
 
 9 
The classification system as a whole has demonstrated good inter-rater reliability [14] 1 
as well as predictive ability [15]. The LANSS has demonstrated good discriminate 2 
validity [27]. 3 
 4 
Subjects scoring 12 or more on the LANSS scale were classified as NS. The LANSS 5 
questionnaire was designed to detect pain of predominantly neuropathic origin, a cut 6 
off score of ≥12 is indicative for a likely contribution of neuropathic pain mechanisms 7 
to the patients pain [27]. Mechanisms underlying neuropathic pain may be both 8 
central or peripheral [28], however items within the LANSS scale are primarily 9 
concerned with identifying positive features of neuropathic pain, such as hyperalgesia 10 
and allodynia in areas distant to the lesion which are hall mark signs for central pain 11 
mechanisms [29, 30].  12 
 13 
In our earlier papers [12, 14] we referred to the group with a LANSS score ≥ 12 as 14 
“Central Sensitization”. In retrospect, this was not the most appropriate term and was 15 
probably misleading. In the present paper we refer to the group with a LANSS scale ≥ 16 
12 as “Neuropathic Sensitization”. “Neuropathic” to more adequately reflect the 17 
construct of the LANSS scale and “Sensitization” as the LANSS tests primarily for 18 
positive signs indicative for gain of function. The only item within the LANSS testing 19 
for negative signs is the test for altered pin-prick sensation.  20 
 21 
Subjects scoring less than 12 on the LANSS scale and with at least two or more 22 
positive tests in two of four different categories: reflexes; muscle power; light touch; 23 
or pinprick sensitivity [14] were classified as “Denervation”. We chose the term 24 
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“Denervation” as it encompasses both ventral (efferent) and dorsal (afferent) root 1 
dysfunction.  2 
 3 
Subjects in group PNS are characterized by positive nerve provocation tests [31] with 4 
a LANSS score < 12 and in the absence of marked neurological deficits. The term 5 
“Peripheral Nerve Sensitization” reflects potential peripheral mechanisms such as 6 
induction of mechanosensitive sodium channels in the nerve sheath as a consequence 7 
of focal inflammation [32]. Nerve mechanosensitivity to pressure and stretch in the 8 
absence of nerve damage has been demonstrated in animal nerve inflammation 9 
models [33, 34], and can be observed clinically in patients with radiating arm pain 10 
[35] or leg pain [36]. The term “Peripheral Nerve Sensitization” describes a pain state 11 
with marked nerve mechanosensitivity in the absence of neuropathic pain and 12 
denervation.  13 
 14 
Group M consists of subjects with a LANSS score < 12, without marked neurological 15 
deficits and negative nerve provocation tests. These clinical features indicate 16 
“pseudoradicular” or somatic referred pain, as neural involvement in the subjects’ 17 
pain is unlikely. The main mechanism for somatic referred pain is convergence, where 18 
afferent nerve fibers from the leg and from structures in the lower back converge upon 19 
the same viscerosomatic neurons in the dorsal horn of the spinal cord [37]. 20 
Examiners 21 
Two examiners (AS and KL), trained simultaneously by RR in the use of the QST 22 
equipment, carried out all QST testing. The QST examiners were blinded to the 23 
results of the physical examination.  24 
 
 11 
Data management  1 
QST data that were not normally distributed were transformed logarithmically before 2 
statistical analysis. The numbers of paradoxical heat sensations during the thermal 3 
sensory limen procedure, cold pain thresholds, heat pain thresholds and vibration 4 
detection thresholds were normally distributed as raw data. All other QST parameters 5 
were normally distributed after logarithmical transformation.  6 
To facilitate comparisons between parameters originally measured in different units, 7 
normalized data for each of the QST parameters were converted to z-scores using 8 
means and SDs from the control group  (z-score = Scoresingle patient -  Meancontrols / 9 
SDcontrols) [17]. A z-score of zero characterizes a value matching the group mean of 10 
the healthy control subjects. Positive z-scores indicate a gain of function where the 11 
patient is more sensitive to the tested stimulus compared to controls (hyperalgesia, 12 
allodynia, hyperpathia) and negative z-scores indicate the patient has a loss of 13 
sensation (hypoesthesia) compared to controls.  14 
 15 
One-way ANOVAs and Chi square tests were used to analyze the difference in 16 
general measures between groups (Table 1).  17 
Two way ANOVAs were conducted for each QST parameter to test interaction effects 18 
of group with body region and between subject main effects (group). The aim was to 19 
investigate relationships of QST data with diagnostic groups. Where main effects or 20 
interactions were significant, Tukey HSD post hoc tests were used to control for 21 
multiple testing. All QST data are presented as Z-scores (mean ± SEM) unless 22 
otherwise indicated. SPSS version 17 (SPSS Inc., Chicago, USA) was used for 23 
statistical analysis. 24 
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3. Results 1 
Subjects 2 
Subjects had a mean age of 48 years and 39% were men. Age, gender, pain duration 3 
and proportion of patients with pain below the knee were comparable between groups 4 
( p > 0.50). Subjects with a score of 12 or more on the LANSS scale [27] were 5 
classified as Neuropathic Sensitization (n=20). The remaining symptomatic subjects 6 
(n=57) who had a LANSS scale score of less than 12 plus negative signs such as 7 
hypoesthesia, muscle weakness or hyporeflexia were classified as Denervation 8 
(n=28). Of the remaining 29 symptomatic subjects, 9 exhibited positive neural 9 
provocation tests, and were classified as Peripheral Nerve Sensitization. All other 10 
subjects were classified as Musculoskeletal (n=20) as there was no suggestion of 11 
neural involvement (Figure 1). For detailed subject characteristics please see Table 1. 12 
QST findings 13 
Results showed relationships between QST data and diagnostic groups as there were 14 
differences in QST parameters between groups across the tested body regions (group 15 
main effect) (Table 2). All group main effects were between symptomatic subject 16 
groups and the asymptomatic group. No significant differences were found between 17 
the four symptomatic subject groups. Warm detection threshold was the only 18 
parameter where the difference between groups varied significantly according to 19 
region (significant group by region interaction), however no group main effects could 20 
be detected for this parameter (Table 2). Allodynia was rare, there was one outlier 21 
with severe allodynia over the back and paradoxical heat sensation was generally 22 
more frequent at the affected foot for group Denervation, although these differences 23 
were not significant at group level (Figure 3). Significant main effects for region 24 
 
 13 
across groups were not further analysed nor discussed, as these do not relate to the 1 
research question. 2 
QST procedures reveal differences between groups Neuropathic Sensitization, 3 
Denervation and controls  4 
The complete sensory profiles of the diagnostic groups Neuropathic Sensitization, 5 
Denervation, Peripheral Nerve Sensitization, and Musculoskeletal over the foot, 6 
lumbar spine, and dorsum of the hand are displayed in Figure 3. When comparing 7 
symptomatic subject groups and asymptomatic controls, we found significant group 8 
main effects for cold pain threshold, mechanical detection threshold, mechanical pain 9 
threshold and mechanical pain sensitivity (Table 2).  10 
 11 
Post hoc analysis with correction for multiple testing (Tukey HSD) for group main 12 
effects revealed that group Neuropathic Sensitization had hyperalgesia to cold (CPT) 13 
and to pinprick (MPT, MPS, all p<0.05). Group Denervation also showed cold 14 
hyperalgesia and in addition higher mechanical detection threshold indicating 15 
mechanical hypaesthesia (MDT, p<0.05). For mean differences, F and p values, 16 
please see Table 2. 17 
 18 
4. Discussion 19 
The results supported construct validity, as relationships between QST data and 20 
diagnostic groups could be demonstrated. QST parameters differed between two 21 
groups of subjects with leg pain and the group of asymptomatic subjects: Subjects in 22 
group Neuropathic Sensitization showed marked signs of pain hypersensitivity, while 23 
sensory deficits were most pronounced in group Denervation. The QST findings in 24 
 
 14 
these two groups match the presumed underlying pathomechanisms: Dominant 1 
neuropathic pain mechanisms with sensory sensitization in group Neuropathic 2 
Sensitization and mechanisms responsible for loss of conduction in group 3 
Denervation. In contrast, groups Peripheral Nerve Sensitization and Musculoskeletal 4 
were not significantly different to healthy controls across all QST parameters. 5 
 6 
Decreased mechanical pain thresholds and cold hyperalgesia as observed in group 7 
Neuropathic Sensitization are signs consistent with central sensitization [28]. Central 8 
sensitization may arise as a result of a number of different mechanisms. Diminished 9 
control of pain including cell death of inhibitory interneurons in the dorsal horn may 10 
contribute to enhanced pain processing [28] as well as changed descending 11 
modulatory mechanisms from the brain stem [38, 39]. Additionally, secondary 12 
changes in cortical and subcortical brain regions, triggered by cognitions, emotions 13 
and attention may further add to central sensitization and development of spontaneous 14 
activity and pain [40, 41]. Another mechanism potentially contributing to 15 
augmentation of central pain processing is deafferentation: Clinical and QST 16 
examinations revealed deficits in large fibre function not only in group Denervation 17 
but also in group Neuropathic Sensitization, indicating nerve fibre damage that for the 18 
latter group may have induced secondary sensitization of higher order nociceptive 19 
neurons [42]. QST findings from patients with other conditions thought to involve 20 
central sensitization such as whiplash associated disorders [43], LBP [44] or 21 
fibromyalgia [45] have also shown increased sensitivity to thermal and mechanical 22 
pain stimuli consistent with findings in the present study. Central sensitization of the 23 
nociceptive system is one of the main mechanisms contributing to neuropathic pain 24 
[46]. 25 
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  1 
Increased mechanical detection thresholds were found in group Denervation when 2 
compared to healthy controls, this was most pronounced over the foot. Additionally, 3 
although not significant, group Denervation showed the most pronounced deficits in 4 
vibration, cold and warm detection over the foot (Fig. 3), consistent with a loss of 5 
conduction. One possible explanation for the significantly elevated mechanical 6 
detection threshold found in group Denervation could be mechanical compression of 7 
the nerve root caused by prolapsed IVD tissue, osteophytes, facet joint hypertrophy or 8 
ligamentum flavum hypertrophy [47]. Also chemical irritation of the nerve roots may 9 
have similar effects. Proinflammatory cytokines such as tumor necrosis factor  10 
released from nucleus pulposus cells or from inflamed arthritic facet joints can enter 11 
the epidural space, contact nerve roots and thereby induce radicular symptoms with 12 
large and small fibre deficits [48, 49].  13 
 14 
A recent study [25] compared somatosensory profiles of subjects with somatic 15 
referred pain (n=15) with subjects with radicular pain (n=12) and found that both 16 
were significantly different to a healthy control group. The authors hypothesized that 17 
mild root compression or an inflammatory perturbation of nerve roots in people with 18 
pseudoradicular pain as well as in people with radicular pain may explain this 19 
phenomenon. In contrast, the present study showed, in comparison to healthy 20 
controls, no significant sensory dysfunction in groups Peripheral Nerve Sensitization 21 
and Musculoskeletal, which are clinically comparable to patients with 22 
“pseudoradicular symptoms”. The reason for this may lie in a more differentiated 23 
subclassification of subjects and consequently higher within group homogeneity.  24 
 25 
 
 16 
Some limitations should be pointed out. First of all, interaction effects between group 1 
and body region could not be demonstrated. This indicates that only generalized 2 
sensory changes over the entire body could be shown, but not localized changes. Also, 3 
statistical analysis of QST data revealed significant differences only between two of 4 
the four symptomatic groups and the asymptomatic group. This implies, firstly, that 5 
construct validity could only be demonstrated for two of the groups, but not for the 6 
classification as a whole. Secondly, the fact that no differences were found between 7 
patient groups weakens conclusions in regard to construct validity. One possible 8 
explanation is that group Peripheral Nerve Sensitization was unexpectedly small with 9 
higher standard errors as a result. In addition, it is well known that psychosocial 10 
factors such as hypervigilance or catastrophizing significantly influence pain 11 
perception, however data in this respect were not available for the present study.  12 
5. Conclusion 13 
The results of this study provide preliminary evidence for the construct validity for 14 
two of the four groups used in the new classification system as significant differences 15 
of QST determined sensory and pain thresholds in groups Neuropathic Sensitization 16 
and Denervation when compared to a group of asymptomatic subjects were shown. 17 
These differences match presumed underlying mechanisms: Sensory deficits in group 18 
Denervation and pain hypersensitivity in group Neuropathic Sensitization. Future 19 
research should include assessment of further psychosocial covariates such as 20 
catastrophizing or hypervigilance and focus on achieving equal group sizes.  21 
 22 
 23 
 24 
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Figure 1: Classification algorithm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*LANSS: Leeds Assessment of Neuropathic Symptoms and Signs [27] 
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Excluded (n=85) 
Not meeting inclusion criteria 
- Average pain rating below 3 (n=23) 
- Bilateral leg pain (n=15) 
- Rheumatoid arthritis (n=5) 
- Diabetes (n=4) 
Refused to participate  (n=26) 
Other reasons (n=12) 
Assessed for Eligibility 
(n=162) 
Allocated to QST testing (n=77) 
 
Lost to follow up (n=0) 
 
Analysed n= 77 
Lost to analysis n= 0 
Figure 2: Participant flow diagram 
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Figure 3: QST profiles 
 
 Group Neuropathic Sensitization 
 Group Denervation 
 Group Peripheral Nerve Sensitization 
 Group Musculoskeletal 
 
CDT, cold detection threshold; WDT, warm detection threshold; TSL, thermal sensory limen; CPT, 
cold pain threshold; HPT, heat pain threshold; PPT, pressure pain threshold; MPT, mechanical pain 
threshold; MPS, mechanical pain sensitivity; WUR, wind up ratio; MDT, mechanical detection 
threshold; VDT, vibration detection threshold; PHS, paradoxical heat sensation; DMA, dynamic 
mechanical allodynia. 
 
The graphs in Figure 3 display the variance of group means (groups NS, D, PNS and M) from the mean 
of the asymptomatic controls in standardized units (z-scores). Positive z-scores indicate a gain of 
function, negative z-scores indicate a loss of function. 
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Table 1: Demographic and clinical data by diagnostic classification for subjects with 
LBRLP 
 
 Total Neuropathic Denervation Peripheral Musculo- p valuea 
  Sensitization  Nerve skeletal  
    Sensitization 
 
n (%) 77 20 (26) 28 (36) 9 (12) 20 (26)  
Age  47.8 (13.1) 47.5 (13.4) 48.2 (12.2) 44.3 (14.0) 49.2 (14.2) .83a 
Gender (% male) 40 35 39 41 45 .92b 
Pain below knee (%) 76.3 80.0 71.4 88.9 73.7 .71b 
Pain duration (months)§ 7.5 (4.0) 7.0 (5.1) 7.3 (3.3) 6.0 (2.8) 10.7 (4.3) .76c 
      
Values presented are means (Standard deviations) or percentage unless otherwise 
indicated 
§ Median (interquartile range) 
a One-way ANOVA; 
b 2 test 
c Kruskall Wallis test 
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Table 2: Statistics from two-way Analysis of variance comparing z-scores for QST 
parameters between four symptomatic groups and one asymptomatic group over 
different body regions 
 
QST 
parameter 
Group 
main 
effects 
 Tukey 
HSD post 
hoc for 
group 
main 
effects 
   Body 
region 
main 
effects 
 Inter-
action 
region 
by 
group 
 
 F-
value 
p-
value 
Mean 
difference 
(z-score) 
p-
value 
95% 
Confidence 
Interval 
 F-
value 
p-
value 
F-
value 
p-
value 
     upper 
bound 
lower 
bound 
    
CDT 0.7 0.563     14.5 0.001 1.3 0.234 
WDT 1.1 0.374     2.9 0.062 2.1 0.042 
TSL 1.9 0.342     0.1 0.654 1.3 0.361 
CPT 3.3 0.015     7.5 0.001 1.0 0.428 
C-NS   -1.09 0.019 -2.06 -0.12     
C-D   -0.94 0.038 -1.84 -0.03     
C-PNS   -1.08 0.108 -2.3 0.14     
C-M   -0.56 0.495 -1.53 0.41     
HPT 0.5 0.891     0.6 0.845 0.9 0.531 
MDT 3.7 0.007     4.1 0.02 1.6 0.354 
C-NS   0.7509 0.058 -0.012 1.52     
C-D   .9543 0.003 0.24 1.67     
C-PNS   0.4689 0.659 -0.5 1.43     
C-M   0.7188 0.078 -0.05 1.49     
MPT 3.9 0.006     0.6 0.540 0.7 0.789 
C-NS   -.8482 0.005 -1.51 -0.18     
C-D   -0.3347 0.561 -0.95 0.28     
C-PNS   -0.2325 0.937 -1.07 0.60     
C-M   -0.652 0.058 -1.32 0.01     
MPS 2.5 0.047     0.6 0.550 0.7 0.703 
C-NS   -1.1798 0.033 -2.29 -0.06     
C-D   -0.8415 0.168 -1.88 0.2     
C-PNS   -0.3507 0.957 -1.75 1.05     
C-M   -0.8075 0.267 -1.92 0.31     
WUR 0.4 0.493     4.9 0.001 0.9 0.910 
VDT 1.3 0.260     2.6 .083 1.6 0.131 
PPT 2.0 0.287     8.7 0.001 1.8 0.405 
DMA 1.0 0.745     1.5 0.734 .7 0.820 
PHS 1.6 0.541     1.2 0.816 .9 0.690 
 
 
CDT, cold detection threshold; WDT, warm detection threshold; TSL, thermal 
sensory limen; CPT, cold pain threshold; HPT, heat pain threshold; PPT, pressure 
pain threshold; MPT, mechanical pain threshold; MPS, mechanical pain sensitivity; 
WUR, wind up ratio; MDT, mechanical detection threshold; VDT, vibration detection 
threshold; PHS, paradoxical heat sensation; DMA, dynamic mechanical allodynia. 
C- Control group 
NS – Group Neuropathic Sensitization 
D – Group Denervation 
PNS – Group Peripheral Nerve Sensitization 
M – Group Muskuloskeletal 
